摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3,5-difluorobenzyl)]amino-5-(2-methylthioethoxy)pyrimidine | 1006599-15-0

中文名称
——
中文别名
——
英文名称
2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3,5-difluorobenzyl)]amino-5-(2-methylthioethoxy)pyrimidine
英文别名
N-[[3-[cyclopentylmethyl(ethyl)amino]-6-methoxypyridin-2-yl]methyl]-N-[(3,5-difluorophenyl)methyl]-5-(2-methylsulfanylethoxy)pyrimidin-2-amine
2-[N-[3-(N-cyclopentylmethyl-N-ethyl)amino-6-methoxypyridin-2-yl]methyl-N-(3,5-difluorobenzyl)]amino-5-(2-methylthioethoxy)pyrimidine化学式
CAS
1006599-15-0
化学式
C29H37F2N5O2S
mdl
——
分子量
557.708
InChiKey
XETBKROTTXLFET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    39
  • 可旋转键数:
    14
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    88.9
  • 氢给体数:
    0
  • 氢受体数:
    10

文献信息

  • Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and medicament comprising the same
    申请人:OHGIYA Tadaaki
    公开号:US20090054474A1
    公开(公告)日:2009-02-26
    A compound represented by the following general formula (I) or a salt thereof, or a solvate thereof: (wherein R 1 , R 2 , R 3 , R 4 and R 5 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R 6 , R 7 and R 8 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R 9 and R 10 are the same or different, and represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group etc., and R 11 represents hydrogen atom, a halogen atom, a lower alkoxy group, a (lower alkyl)thio(lower alkoxy) group, a (lower alkyl)sulfinyl(lower alkoxy) group, a (lower alkyl)sulfonyl(lower alkoxy) group etc.), which has potent inhibitory activity on CETP.
    由以下一般式(I)表示的化合物或其盐,或其溶剂合物:(其中R1、R2、R3、R4和R5相同或不同,代表氢原子、卤原子、较低烷基等,R6、R7和R8相同或不同,代表氢原子、卤原子、较低烷基等,R9和R10相同或不同,代表氢原子、较低烷基、(较低环烷基)(较低烷基)等,R11代表氢原子、卤原子、较低烷氧基、(较低烷基)(较低烷氧基)基、(较低烷基)亚基(较低烷氧基)基、(较低烷基)砜基(较低烷氧基)基等),对CETP具有强大的抑制活性。
  • NOVEL PYRIMIDINE COMPOUND HAVING BENZYL(PYRIDYLMETHYL)AMINE STRUCTURE AND PHARMACEUTICAL COMPRISING THE COMPOUND
    申请人:Kowa Company. Ltd.
    公开号:EP2055703A1
    公开(公告)日:2009-05-06
    A compound represented by the following general formula (I) or a salt thereof, or a solvate thereof (wherein R1, R2, R3, R4 and R5 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R6, R7 and R8 are the same or different, and represent hydrogen atom, a halogen atom, a lower alkyl group etc., R9 and R10 are the same or different, and represent hydrogen atom, a lower alkyl group, a (lower cycloalkyl)(lower alkyl) group etc., and R11 represents hydrogen atom, a halogen atom, a lower alkoxy group, a (lower alkyl)thio(lower alkoxy) group, a (lower alkyl)sulfinyl(lower alkoxy) group, a (lower alkyl)sulfonyl(lower alkoxy) group etc.), which has potent inhibitory activity on CETP.
    由以下通式(I)代表的化合物或其盐或其溶液 (其中 R1、R2、R3、R4 和 R5 相同或不同,代表氢原子、卤素原子、低级烷基等;R6、R7 和 R8 相同或不同,代表氢原子、卤素原子、低级烷基等;R9 和 R10 相同或不同,代表氢原子、低级烷基、(低级环烷基)(低级烷基)基团等、以及 R11 代表氢原子、卤素原子、低级烷氧基、(低级烷基)(低级烷氧基)基团、(低级烷基)亚磺酰(低级烷氧基)基团、(低级烷基)磺酰(低级烷氧基)基团等),对 CETP 具有强效抑制活性。
  • US7750019B2
    申请人:——
    公开号:US7750019B2
    公开(公告)日:2010-07-06
查看更多